半亩花田 burned 47% of revenue on ads — then regulator asked six questions

半亩花田 (Half-Acre Flower Field) was founded in 2010 in Pingyin, Shandong — China's rose-growing heartland. The couple behind it, 亓云吉 and 商西梅, started with a single body scrub and built it into a mass-market skincare brand on the back of Kuaishou livestreaming. 商西梅 appeared on camera as 'a mother of three,' and the brand's 65% repurchase rate ran well above the 48% industry average. Revenue went from ¥100M in 2019 to ¥2.8B in 2024 — a 28-fold jump in five years.

On 16 January 2026, the company filed its prospectus with the Hong Kong Stock Exchange under its formal name 山东花物堂化妆品股份有限公司. The document revealed the engine behind the growth: in the first nine months of 2025, marketing spend was ¥896M against revenue of ¥1.89B — 47.3% of every yuan earned went to advertising. The brand signed Dilraba Dilmurat as celebrity endorser in 2024 and table-tennis champion Sun Yingsha in 2025. R&D spending over the same period was ¥28.14M — 1.5% of revenue, less than one-thirtieth of the marketing budget.

Seven months earlier, in December 2025, the brand had collaborated with a controversial livestreamer known as 刘二狗 on a poolside promotional stream filled with suggestive physical contact and revealing shots, with 半亩花田 products woven throughout. The clips went viral for the wrong reasons, drawing nationwide accusations of 'lowbrow marketing.' The controversy broke on 5 December 2025 — one week before the company's parent completed a corporate restructuring and management reshuffle ahead of the IPO filing.

The CSRC responded with six questions aimed squarely at the company's governance: whether 10 shareholders each holding under 5% were secretly related; why the founding couple controlled 85.03% of voting rights through layered platforms; why the founder of rival brand 林清轩 (Lin Qingxuan) had bought in 15 days before the filing; whether ¥50M in stock-based compensation had gone to insiders; and the sustainability of an OEM model where nearly half of revenue is burned on marketing.

The regulator's six questions turned the filing into an exposé: marketing-as-moat meant competing on traffic, not product, and governance invited scrutiny.

Marketing-as-moat: 47.3% of revenue went to advertising, R&D was 1.5%. The brand was not competing on product differentiation but on traffic acquisition — a treadmill that gets faster, not easier.

Governance opacity: 85% voting control by one couple, 10 sub-5% shareholders, and a competitor's founder buying in days before filing — each flagged by the CSRC as potential evasion of scrutiny.

The lowbrow livestream was not an isolated incident. In March 2025, Xiaohongshu had already banned the brand for planting fake consumer reviews — the same pattern of trading trust for traffic.

OEM production meant the company owned neither manufacturing nor product IP — its 'core competence' was a Kuaishou following and a media-buying operation in skincare branding.

When marketing is the product, the IPO filing becomes the exposé — a regulator can read the mismatch between ad spend and R&D, and so can every competitor.